Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1984 Nov;20(5):869–873. doi: 10.1128/jcm.20.5.869-873.1984

Stone formation by Ureaplasma urealyticum in human urine and its prevention by urease inhibitors.

S Takebe, A Numata, K Kobashi
PMCID: PMC271462  PMID: 6549013

Abstract

When Ureaplasma urealyticum T-960 was inoculated into normal human urine (10(8) viable cells per ml of urine), a white precipitate formed, with an increase in pH of the infected urine. This precipitate was identified as a mixture of struvite and whitelockite by analysis of the infrared spectrum. Its formation was completely prevented by the addition of 10 microM N-benzoylphosphotriamide, 20 microM N-isopentenoylphosphotriamide, or 0.5 mM caprylohydroxamic acid without the alkalinization of the urine, and the Ureaplasma color change units were also decreased markedly by these compounds. The apparent concentrations for 50% inhibition by N-benzoylphosphotriamide,N-isopentenolyphosphotriamide, and caprylohydroxamic acid against Ureaplasma urease were 7 nM, 2 nM, and 2.2 microM, respectively. From these results, it seems that stone formation by U. urealyticum is prevented with these compounds, that prevention being directly attributable to the inhibition of urease activity, which causes the death of the cells.

Full text

PDF
869

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen J. A. Benurestat, a urease inhibitor for the therapy of infected ureolysis. Invest Urol. 1975 Mar;12(5):381–386. [PubMed] [Google Scholar]
  2. Dixon N. E., Gazzola C., Watters J. J., Blakely R. L., Zerner B. Inhibition of Jack Bean urease (EC 3.5.1.5) by acetohydroxamic acid and by phosphoramidate. An equivalent weight for urease. J Am Chem Soc. 1975 Jul 9;97(14):4130–4131. doi: 10.1021/ja00847a044. [DOI] [PubMed] [Google Scholar]
  3. Ford D. K. Inhibition of growth of T-strain mycoplasmas by hydroxamic acids and by aurothiomalate. Antimicrob Agents Chemother. 1972 Nov;2(5):340–343. doi: 10.1128/aac.2.5.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Friedlander A. M., Braude A. I. Production of bladder stones by human T mycoplasmas. Nature. 1974 Jan 4;247(5435):67–69. doi: 10.1038/247067b0. [DOI] [PubMed] [Google Scholar]
  5. Griffith D. P., Musher D. M., Campbell J. W. Inhibition of bacterial urease. Invest Urol. 1973 Nov;11(3):234–238. [PubMed] [Google Scholar]
  6. Griffith D. P., Musher D. M. Prevention of infected urinary stones by urease inhibition. Invest Urol. 1973 Nov;11(3):228–233. [PubMed] [Google Scholar]
  7. Hase J., Kobashi K. Inhibition of Proteus vulgaris urease by hydroxamic acids. J Biochem. 1967 Sep;62(3):293–299. [PubMed] [Google Scholar]
  8. Hase J., Kobashi K., Kawaguchi N., Sakamoto K. Antimicrobial activity of hydroxamic acids. Chem Pharm Bull (Tokyo) 1971 Feb;19(2):363–368. doi: 10.1248/cpb.19.363. [DOI] [PubMed] [Google Scholar]
  9. Ichiyama A. [Tryptophan-5-monooxygenase]. J Biochem. 1972 Oct;44(10):825–848. [PubMed] [Google Scholar]
  10. KOBASHI K., HASE J., UEHARA K. Specific inhibition of urease by hydroxamic acids. Biochim Biophys Acta. 1962 Dec 4;65:380–383. doi: 10.1016/0006-3002(62)91067-3. [DOI] [PubMed] [Google Scholar]
  11. Kishima M., Hashimoto K. In vitro sensitivities to antimicrobial drugs of ureaplasmas isolated from the bovine respiratory tract, genital tract and eye. Res Vet Sci. 1979 Sep;27(2):218–222. [PubMed] [Google Scholar]
  12. Kobashi K. [Inhibition of urease activity by hydroxamic acid and its practical application]. Seikagaku. 1972 May;44(5):187–204. [PubMed] [Google Scholar]
  13. Lamm D. L., Johnson S. A., Friedlander A. M., Gittes R. F. Medical therapy of experimental infection stones. Urology. 1977 Nov;10(5):418–421. doi: 10.1016/0090-4295(77)90125-x. [DOI] [PubMed] [Google Scholar]
  14. Masover G. K., Benson J. R., Hayflick L. Growth of T-strain mycoplasmas in medium without added urea: effect of trace amounts of urea and of a urease inhibitor. J Bacteriol. 1974 Feb;117(2):765–774. doi: 10.1128/jb.117.2.765-774.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Millner O. E., Jr, Andersen J. A., Appler M. E., Benjamin C. E., Edwards J. G., Humphrey D. T., Shearer E. M. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones. J Urol. 1982 Feb;127(2):346–350. doi: 10.1016/s0022-5347(17)53779-9. [DOI] [PubMed] [Google Scholar]
  16. Munakata K., Kobashi K., Takebe S., Hase J. Therapy for urolithiasis by hydroxamic acids. III. Urease inhibitory potency and urinary excretion rate of N-acylglycinohydroxamic acids. J Pharmacobiodyn. 1980 Sep;3(9):451–456. doi: 10.1248/bpb1978.3.451. [DOI] [PubMed] [Google Scholar]
  17. Munakata K., Mochida H., Kondo S., Suzuki Y. Mutagenicity of N-acylglycinohydroxamic acids and related compounds. J Pharmacobiodyn. 1980 Nov;3(11):557–561. doi: 10.1248/bpb1978.3.557. [DOI] [PubMed] [Google Scholar]
  18. Okuda H., Fujii S. [Direct colorimetry of ammonia in the blood]. Saishin Igaku. 1966 Mar;21(3):622–627. [PubMed] [Google Scholar]
  19. Romano N., Tolone G., Ajello F., La Licata R. Adenosine 5'-triphosphate synthesis induced by urea hydrolysis in Ureaplasma urealyticum. J Bacteriol. 1980 Nov;144(2):830–832. doi: 10.1128/jb.144.2.830-832.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shepard M. C., Lunceford C. D. Occurrence of urease in T strains of Mycoplasma. J Bacteriol. 1967 May;93(5):1513–1520. doi: 10.1128/jb.93.5.1513-1520.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shimbayashi K., Obara Y., Yonemura T., Deguchi N., Nakanishi M. Effect of caprylohydroxamic acid on ruminal urease. Nihon Juigaku Zasshi. 1973 Aug;35(4):327–334. doi: 10.1292/jvms1939.35.327. [DOI] [PubMed] [Google Scholar]
  22. Takeuchi H., Kobashi K., Yoshida O. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative. Invest Urol. 1980 Sep;18(2):102–105. [PubMed] [Google Scholar]
  23. Takeuchi H., Okada Y., Kobashi K., Yoshida O. Treatment of infected urinary stones in rats by a new hydroxamic acid, "N-(pivaloyl)glycinohydroxamic acid. Urol Res. 1982;10(4):217–219. doi: 10.1007/BF00255948. [DOI] [PubMed] [Google Scholar]
  24. Taylor-Robinson D., Manchee R. J. Adherence of mycoplasmas to glass and plastic. J Bacteriol. 1967 Nov;94(5):1781–1782. doi: 10.1128/jb.94.5.1781-1782.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES